Skip to main content
editorial
. 2022 Dec 1;108(6):1463–1467. doi: 10.3324/haematol.2022.282025

Table 1.

Summary of studies to date evaluating the prognosis in DUSP22-rearranged ALK-negative anaplastic large cell lymphoma.

graphic file with name 1081463.tab1.jpg